Unaudited Financial Results for the quarter ended June 30, 2025.
Awaiting price reaction for this filing.
Auditors R.R. Tibrewala & Co. issued a qualified conclusion on Omkar Speciality Chemicals' Q1 FY26 results. The company was under the Corporate Insolvency Resolution Process (CIRP) during the quarter and has not prepared results for the first three quarters of FY25, so year-on-year comparisons are unavailable. The company reported a loss for the quarter and its net worth is negative, raising material uncertainty about its ability to continue as a going concern. The NCLT approved a resolution plan on July 31, 2025, shortly after the reporting period, on the basis of which management prepared results assuming continued operations.
Shareholders face significant uncertainty: the company is loss-making with negative net worth and was undergoing insolvency proceedings, though the approved resolution plan offers a potential turnaround path. Expect heightened stock price volatility as the market digests the revival prospects under the new resolution framework.